Total Payments
$10,496
2024 Payments
$115.37
Companies
8
Transactions
14
Payment Breakdown by Category
Research$9,778 (93.2%)
Food & Beverage$566.79 (5.4%)
Education$151.26 (1.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $9,778 | 4 | 93.2% |
| Food and Beverage | $566.79 | 7 | 5.4% |
| Education | $151.26 | 3 | 1.4% |
Payments by Type
Research
$9,778
4 transactions
General
$718.05
10 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $9,778 | 4 | $0 (2019) |
| Novo Nordisk Inc | $253.92 | 3 | $0 (2023) |
| Rhythm Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $104.77 | 1 | $0 (2017) |
| PFIZER INC. | $99.34 | 2 | $0 (2024) |
| Medtronic, Inc. | $76.99 | 1 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $42.00 | 1 | $0 (2022) |
| Azurity Pharmaceuticals, Inc. | $16.03 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $115.37 | 3 | Medtronic, Inc. ($76.99) |
| 2023 | $236.26 | 2 | Rhythm Pharmaceuticals, Inc. ($125.00) |
| 2022 | $42.00 | 1 | TOLMAR Pharmaceuticals, Inc. ($42.00) |
| 2019 | $1,973 | 2 | Eli Lilly and Company ($1,941) |
| 2018 | $5,707 | 2 | Eli Lilly and Company ($5,707) |
| 2017 | $2,422 | 4 | Eli Lilly and Company ($2,130) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $76.99 | General |
| Category: Durable Pump | ||||||
| 10/08/2024 | PFIZER INC. | GENOTROPIN (Drug), NGENLA | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: ENDOCRINE DISEASE | ||||||
| 08/29/2024 | Azurity Pharmaceuticals, Inc. | TRIPTODUR (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/08/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $111.26 | General |
| 01/25/2023 | Rhythm Pharmaceuticals, Inc. | Imcivree (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Genetic Disease | ||||||
| 10/17/2022 | TOLMAR Pharmaceuticals, Inc. | FENSOLVI (Drug) | Education | In-kind items and services | $42.00 | General |
| Category: Central Precocious Puberty (CPP) | ||||||
| 08/07/2019 | Novo Nordisk Inc | Victoza (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 01/08/2019 | Eli Lilly and Company | TRULICITY (Drug) | — | Cash or cash equivalent | $1,941.00 | Research |
| Study: A RANDOMIZED, DOUBLE-BLIND STUDY WITH AN OPEN-LABEL EXTENSION COMPARING THE EFFECT OF ONCE-WEEKLY DULAGLUTIDE WITH PLACEBO IN PEDIATRIC PATIENTS WITH TYPE 2 DIABETES MELLITUS-AWARD-PEDS- ASSESSMENT OF WEEKLY ADMINISTRATION OF LY2189265 IN DIABETES-PEDIATRIC STUDY • Category: Diabetes | ||||||
| 01/30/2018 | Eli Lilly and Company | TRULICITY (Drug) | — | Cash or cash equivalent | $3,865.00 | Research |
| Study: A RANDOMIZED, DOUBLE-BLIND STUDY WITH AN OPEN-LABEL EXTENSION COMPARING THE EFFECT OF ONCE-WEEKLY DULAGLUTIDE WITH PLACEBO IN PEDIATRIC PATIENTS WITH TYPE 2 DIABETES MELLITUS-AWARD-PEDS- ASSESSMENT OF WEEKLY ADMINISTRATION OF LY2189265 IN DIABETES-PEDIATRIC STUDY • Category: Diabetes | ||||||
| 01/29/2018 | Eli Lilly and Company | TRULICITY (Drug) | — | In-kind items and services | $1,841.97 | Research |
| Study: A RANDOMIZED, DOUBLE-BLIND STUDY WITH AN OPEN-LABEL EXTENSION COMPARING THE EFFECT OF ONCE-WEEKLY DULAGLUTIDE WITH PLACEBO IN PEDIATRIC PATIENTS WITH TYPE 2 DIABETES MELLITUS-AWARD-PEDS- ASSESSMENT OF WEEKLY ADMINISTRATION OF LY2189265 IN DIABETES-PEDIATRIC STUDY • Category: Diabetes | ||||||
| 07/25/2017 | Eli Lilly and Company | TRULICITY (Drug) | — | In-kind items and services | $2,129.60 | Research |
| Study: A RANDOMIZED, DOUBLE-BLIND STUDY WITH AN OPEN-LABEL EXTENSION COMPARING THE EFFECT OF ONCE-WEEKLY DULAGLUTIDE WITH PLACEBO IN PEDIATRIC PATIENTS WITH TYPE 2 DIABETES MELLITUS-AWARD-PEDS- ASSESSMENT OF WEEKLY ADMINISTRATION OF LY2189265 IN DIABETES-PEDIATRIC STUDY • Category: Diabetes | ||||||
| 04/03/2017 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $110.39 | General |
| 04/02/2017 | Alexion Pharmaceuticals, Inc. | Strensiq (Drug) | Food and Beverage | In-kind items and services | $104.77 | General |
| Category: Endocrinology | ||||||
| 03/30/2017 | PFIZER INC. | GENOTROPIN (Drug) | Education | In-kind items and services | $76.99 | General |
| Category: ENDOCRINE DISEASE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND STUDY WITH AN OPEN-LABEL EXTENSION COMPARING THE EFFECT OF ONCE-WEEKLY DULAGLUTIDE WITH PLACEBO IN PEDIATRIC PATIENTS WITH TYPE 2 DIABETES MELLITUS-AWARD-PEDS- ASSESSMENT OF WEEKLY ADMINISTRATION OF LY2189265 IN DIABETES-PEDIATRIC STUDY | Eli Lilly and Company | $9,778 | 4 |
About Sachin Bendre, MD PHD
Sachin Bendre, MD PHD is a Pediatrics healthcare provider based in Charleston, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2009. The National Provider Identifier (NPI) number assigned to this provider is 1811125701.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sachin Bendre, MD PHD has received a total of $10,496 in payments from pharmaceutical and medical device companies, with $115.37 received in 2024. These payments were reported across 14 transactions from 8 companies. The most common payment nature is "" ($9,778).
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatrics
- Location Charleston, WV
- Active Since 06/30/2009
- Last Updated 10/03/2013
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1811125701
Products in Payments
- TRULICITY (Drug) $9,778
- Imcivree (Drug) $125.00
- Strensiq (Drug) $104.77
- GENOTROPIN (Drug) $99.34
- MINIMED 780G (Device) $76.99
- FENSOLVI (Drug) $42.00
- Victoza (Drug) $32.27
- TRIPTODUR (Drug) $16.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Charleston
Lara Wine Lee, M.d, M.D
Pediatrics — Payments: $141,439
Pediatrics $141,439
Dr. Neena Champaigne, M.d, M.D
Pediatrics — Payments: $58,981
Pediatrics $58,981
Dr. Allison Eckard, Md, MD
Pediatrics — Payments: $37,829
Pediatrics $37,829
Dr. Stephen Stripling, M.d, M.D
Pediatrics — Payments: $29,486
Pediatrics $29,486
Melissa Henshaw, Md, MD
Pediatrics — Payments: $16,700
Pediatrics $16,700
Dr. Letitia Tierney, Md, MD
Pediatrics — Payments: $14,513
Pediatrics $14,513